The immunology conference is mainly to host presentations from eminent experts across the field to encourage new collaborations in the field of Immunology. Researchers in the relevant fields across the World can present their topics and to discuss the new results.
The Main Theme of this conference is to “Explore your thoughts in the field of Immunology”.
It aims to bring together leading scientists, researchers and scholars to exchange their views and share their experiences in all the aspects of immunology. The conference covers all the topics related to immunology. It includes plenary discussions, keynote lectures, oral and poster presentations by esteemed delegates with the intention of collecting information on Immunology. The conference is to offer chance to young participants to harness their career in all the orientations. It hosts presentations from investigators at every career stage reporting their latest research findings. It will be a great platform to showcase your views and make the conference a grand success.
On behalf of the organizing committee of Immunology conference, we would like to invite you to attend and participate in the ‘International Conference and Exhibition On Immunology’-USA 2018. The conference will be held on Jan 29-31 at Las Vegas,USA.
The purpose of this conference is to provide an opportunity to update the knowledge on immunology and its studies. The presentations by the International and local speakers give information on immunological aspects, allergic diseases and immune systems.
The attendees can find:
We trust you will join us to extend your research and enjoy the unique assets in the conference
|
Day – 1 |
Monday, January 29th, 2018 |
|
08:30 am – 09:00 am |
Registration Desk Opens |
|
09:00 am – 10:00 am |
Welcome Message |
|
10:00 am – 10:30 pm |
Networking Coffee Break & Exhibition Visit |
|
10:30 am – 12:30 pm |
Scientific Session 1 |
|
12:30 pm – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:30 pm |
Poster Session 1 |
|
03:30 pm – 04:00 pm |
Refreshment/Exhibition visit |
|
04:00 pm – 06:00 pm |
Scientific Session 2 |
|
|
Tuesday, January 30th, 2018 |
|
09:00 am – 10:30 am |
Scientific Session 3 |
|
10:30 am – 11:00 am |
Refreshment/Exhibition visit |
|
11:00 am – 12:30 pm |
Poster Session 2 |
|
12:30 am – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:00 pm |
E – poster presentation 1 |
|
03:00 pm – 03:30 pm |
Refreshment/Exhibition visit |
|
03:30 pm – 06:00 pm |
Scientific Session 4 |
|
|
Wednesday, January 31th, 2018 |
|
09:00 am – 10:30 am |
Scientific Session 5 |
|
10:30 am – 11:00 am |
Refreshment/Exhibition visit |
|
11:00 am – 12:30 pm |
Poster Session 3 |
|
12:30 am – 01:30 pm |
Networking Lunch & Exhibition Visit |
|
01:30 pm – 03:00 pm |
Scientific Session 6 |
|
03:00 pm – 03:30 pm |
Refreshment/Exhibition visit |
|
03:30 pm – 06:00 pm |
Scientific Session 7 |
|
Award ceremony |
|
|
Conference Concludes |
|
|
Conference Details |
Dates |
|
1st Round Abstract Submission opens |
1 June 2017 |
|
1st Round Abstract Submission Deadline |
20 september 2017 |
|
Early Bird Registrations Opens |
15 June 2017 |
|
Early Bird Registration Deadline |
15 November 2017 |
|
Group Registration Deadline |
20 November 2017 |
|
Exhibitor Opportunity Ends |
15 December 2017 |
|
Sponsorship request Deadline |
15 December 2017 |
|
workshop request Submission |
Till 17 December 2017 |
|
Symposium Submission Deadline |
20 December2017 |
|
Media Partner request Till |
22 December 2017 |
|
Advertising Opportunity Request |
24 December 2017 |
|
Volunteer Opportunity Ends |
24 December 2017 |
|
Press pass Opportunity Deadline |
25 December 2017 |
|
Presentation Dates |
29 – 31 Jan 2018 |
|
(a) |
Immunological memory |
|
(b) |
Antibody - mediated immunity |
|
(c) |
Germinal centres |
|
(d) |
Primary and Secondary Immune Responses |
|
(e) |
Affinity maturation & Selection |
|
(f) |
Vaccine development |
|
(g) |
Others |
|
(a) |
Infectious Diseases, Emerging and Reemerging Diseases |
|
(b) |
Tumor Immunogenicity |
|
(c) |
Cancer Vaccines |
|
(d) |
Antibody Therapy of Cancer |
|
(e) |
Cancer Immunology & Immunotherapy |
|
(f) |
Immune Check point Inhibitors |
|
(g) |
Others |
|
(a) |
Mucosal Immunology |
|
(b) |
Cellular and Molecular Immunology Research |
|
(c) |
Pediatric immunology |
|
(d) |
Ocular Immunology |
|
(e) |
Immunotherapeutics |
|
(f) |
Diagnostic Immunology |
|
(g) |
Autoimmune disease |
|
(h) |
Immunomodulation |
|
(i) |
Others |
|
(a) |
Immune Tolerance |
|
(b) |
Vaccines and Immunotherapy |
|
(c) |
Immunodeficiency |
|
(d) |
Bacterial Pathogenesis and Immunology |
|
(e) |
Nutritional Immunology |
|
(f) |
Neuroimmunology |
|
(g) |
Others |
|
(a) |
Transplantation Rejection |
|
(b) |
Hair Transplantation |
|
(c) |
Organ transplantation failure |
|
(d) |
Pediatric Transplant |
|
(e) |
Transplantation Technologies & Research |
|
(f) |
Bone marrow Transplant |
|
(g) |
Others |
|
(a) |
Parasite immunology, Autoimmunity |
|
(b) |
Immunomodulation |
|
(c) |
Immunologic surveillance and tumor immunity |
|
(d) |
Delayed-type hypersensitivity or cellular immunity |
|
(e) |
Molecular Immunology |
|
(f) |
Immunotherapy tumors |
|
(g) |
Others |
|
(a) |
Innate Immunity and Inflammation |
|
(b) |
Allergy and Infectious Diseases |
|
(c) |
Microbial Immunology |
|
(d) |
Molecular Neuroscience |
|
(e) |
Novel Approaches in Cancer & Tumor |
|
(f) |
Others |
|
(a) |
Allergy epidemiology, prevention and risk factors |
|
(b) |
Infection and allergy |
|
(c) |
Microbiomes: epithelial, respiratory and gastrointestinal |
|
(d) |
Comparative and Veterinary allergology |
|
(e) |
Other |
|
(a) |
Adaptive immunity |
|
(b) |
Innate immunity and complement |
|
(c) |
Other basic immunology |
|
(d) |
Immunodeficiency |
|
(e) |
Autoimmunity |
|
(f) |
Allergens:characterisation (new allergens) |
|
(g) |
Allergic inflammation, mast cells and eosinophils |
|
(h) |
Allergic immune response |
|
(i) |
Mechanisms |
|
(j) |
Others |
|
(a) |
Immunotherapy (clinics) |
|
(b) |
Immunotherapy mechanisms |
|
(c) |
Immunotherapy vaccines |
|
(d) |
Primary Immunodeficiency |
|
(e) |
Others |
|
(a) |
Immune regulation |
|
(b) |
Immunological aspects of infection |
|
(c) |
Immunological aspects of skin diseases |
|
(d) |
Immunological aspects of allergy and anaphylaxis |
|
(e) |
Other |
|
(a) |
Pulmonology |
|
(b) |
Hives |
|
(c) |
Eczema |
|
(d) |
Sinusitis |
|
(e) |
Asthma |
|
(f) |
Hay fever |
|
(g) |
Other |
|
(a) |
Immune homeostasis |
|
(b) |
Immune modulation of tumors |
|
(c) |
Tissue specific autoimmunity |
|
(d) |
Central nervous system –targeted autoimmunity |
|
(e) |
Next generation immune based therapies |
|
(f) |
Other |
|
(a) |
Biology of innate and adaptive immune responses at mucosal surfaces |
|
(b) |
The host-microbiota interface |
|
(c) |
Impact of the microbiota on systemic immunity |
|
(d) |
Mucosal immunity in humans |
|
(e) |
Translational immunology in inflammatory bowel disease |
|
(f) |
Mechanisms of antigen uptake |
|
(g) |
Regulation of immunity in the intestine, lung and UG tract |
|
(h) |
Mucosal co-factors: Infections and diseases |
|
(i) |
Others |
|
(a) |
Immunological paradox of pregnancy |
|
(b) |
Factors involved in trophoblast invasion |
|
(c) |
Immune cells and cytokines in implantation |
|
(d) |
Mucosal immunity and sexually transmitted infections and Diseases |
|
(e) |
Immune-mediated sub-fertility and pregnancy complications |
|
(f) |
Immunogenetics in reproduction |
|
(g) |
Other |
|
(a) |
Neuro immune interaction |
|
(b) |
Neurophysiology/epilepsy |
|
(c) |
Autoimmune neuropathies |
|
(d) |
Neuroimmunological infectious diseases |
|
(e) |
Neurovirology |
|
(f) |
Other |
|
(a) |
Role in health and disease |
|
(b) |
Cutting edge research in nutritional immunology |
|
(c) |
Nutrition-inflammation interactions |
|
(d) |
Obesity, inflammation and immunity |
|
(e) |
Immune profiling in metabolic diseases |
|
(f) |
White-brown adipocyte plasticity and inflammation |
|
(g) |
Nutrition, immunity and chronic age-related diseases |
|
(h) |
Nutrient-gene interactions in the immune system |
|
(i) |
Nutrition and immune cell signaling |
|
(j) |
Nutritional immunologyold challenges & new approaches |
|
(k) |
Other |
|
(a) |
Computational methods for immunogenicity evaluation |
|
(b) |
Immunogenicity assessment for peptide therapeutics |
|
(c) |
Immunogenicity assessment for biosimilars |
|
(d) |
Immunotoxicity evaluation of novel drug candidates |
|
(e) |
Protein aggregation, biological activity & immunogenicity |
|
(f) |
Others |
|
(a) |
Immune responses to fungal pathogens |
|
(b) |
Components of Innate Immunity to Fungi |
|
(c) |
Structures and Signals that Impact Fungal Immunity |
|
(d) |
Adaptive and Maladaptive Immunity to Fungi |
|
(e) |
Host-Fungal Pathogen Interactions: Systems Biology and Beyond |
|
(f) |
Intracellular Parasitism |
|
(g) |
Harnessing Immunity to Fungi in the Clinic |
|
(h) |
Others |
|
(a) |
Immunoreceptor signalings: Receptors and pathways |
|
(b) |
Cellular communication, migration and dynamics |
|
(c) |
Systems analysis of cancer and model organisms |
|
(d) |
Human systems immunology |
|
(e) |
Others |